Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079128105> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W2079128105 endingPage "598" @default.
- W2079128105 startingPage "597" @default.
- W2079128105 abstract "The multicenter, randomized, double-blind, double-dummy, placebo-controlled REACTT trial suggested that treatment with tadalafil once daily (OaD) started early after bilateral nerve-sparing radical prostatectomy (nsRP) for prostate cancer may contribute to erectile function (EF)-recovery, which was predefined as achieving an International Index of Erectile Function (IIEF)-EF score ≥22. Here, we report descriptive post-hoc analyses, using the more strict definition for EF-recovery of returning back to the pre-surgery IIEF-EF-level (“back-to-baseline analysis”).REACTT included 422 men <68 years with adenocarcinoma of the prostate and preoperative IIEF-EF ≥22 who underwent nsRP at 50 centers from 9 European countries and Canada. Patients were randomized post-nsRP 1:1:1 to 9-month double-blind treatment (DBT) with tadalafil 5 mg OaD (n = 139), tadalafil 20 mg on-demand (pro-re-nata, PRN; n = 142), or placebo (n = 141), followed by 6-week drug-free washout (DFW) and 3-month open-label tadalafil OaD treatment (OLT).Proportion of patients returning to their preoperative IIEF-EF category (22–25 or ≥26) at the end of DBT, DFW, and OLT.Overall, 92.4% of patients had pre-surgery (baseline) IIEF-EF scores ≥26 (tadalafil OaD 94.2%, PRN 91.6%, placebo 91.5%), 7.4% had IIEF-EF 22–25. At the end of DBT, 22.3% of patients on tadalafil OaD had achieved “back-to-baseline” IIEF-EF, compared with 11.3% on tadalafil PRN and 7.8% on placebo. Of all 58 patients “back-to-baseline” at the end of DBT, only 1 PRN-group patient had started from a baseline IIEF-EF <26. The treatment-group difference at the end of DBT was not maintained after DFW. After 3 months of OLT with tadalafil OaD, the proportion of patients with “back-to-baseline” IIEF-EF had almost doubled in all 3 groups.Changing the definition for EF-recovery from IIEF-EF ≥22 to the more strict definition of “returning back-to-baseline IIEF-EF” had no major impact. Tadalafil OaD started early after nsRP improved drug-assisted EF, but had no effect on unassisted EF following treatment cessation after 9 months." @default.
- W2079128105 created "2016-06-24" @default.
- W2079128105 creator A5037019692 @default.
- W2079128105 date "2014-03-01" @default.
- W2079128105 modified "2023-09-23" @default.
- W2079128105 title "Erection Rehabilitation after Radical Prostatectomy: Definite Purpose, Indefinite Strategy" @default.
- W2079128105 cites W1565464545 @default.
- W2079128105 cites W2000105334 @default.
- W2079128105 cites W2020389062 @default.
- W2079128105 cites W2063333875 @default.
- W2079128105 cites W2120370327 @default.
- W2079128105 cites W2122960977 @default.
- W2079128105 cites W2171081137 @default.
- W2079128105 doi "https://doi.org/10.1016/j.eururo.2013.10.018" @default.
- W2079128105 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24268502" @default.
- W2079128105 hasPublicationYear "2014" @default.
- W2079128105 type Work @default.
- W2079128105 sameAs 2079128105 @default.
- W2079128105 citedByCount "2" @default.
- W2079128105 countsByYear W20791281052014 @default.
- W2079128105 countsByYear W20791281052016 @default.
- W2079128105 crossrefType "journal-article" @default.
- W2079128105 hasAuthorship W2079128105A5037019692 @default.
- W2079128105 hasConcept C121608353 @default.
- W2079128105 hasConcept C126322002 @default.
- W2079128105 hasConcept C126894567 @default.
- W2079128105 hasConcept C141071460 @default.
- W2079128105 hasConcept C142724271 @default.
- W2079128105 hasConcept C168563851 @default.
- W2079128105 hasConcept C204787440 @default.
- W2079128105 hasConcept C27081682 @default.
- W2079128105 hasConcept C2779466945 @default.
- W2079128105 hasConcept C2779929075 @default.
- W2079128105 hasConcept C2780192828 @default.
- W2079128105 hasConcept C2780816001 @default.
- W2079128105 hasConcept C3020768380 @default.
- W2079128105 hasConcept C71924100 @default.
- W2079128105 hasConceptScore W2079128105C121608353 @default.
- W2079128105 hasConceptScore W2079128105C126322002 @default.
- W2079128105 hasConceptScore W2079128105C126894567 @default.
- W2079128105 hasConceptScore W2079128105C141071460 @default.
- W2079128105 hasConceptScore W2079128105C142724271 @default.
- W2079128105 hasConceptScore W2079128105C168563851 @default.
- W2079128105 hasConceptScore W2079128105C204787440 @default.
- W2079128105 hasConceptScore W2079128105C27081682 @default.
- W2079128105 hasConceptScore W2079128105C2779466945 @default.
- W2079128105 hasConceptScore W2079128105C2779929075 @default.
- W2079128105 hasConceptScore W2079128105C2780192828 @default.
- W2079128105 hasConceptScore W2079128105C2780816001 @default.
- W2079128105 hasConceptScore W2079128105C3020768380 @default.
- W2079128105 hasConceptScore W2079128105C71924100 @default.
- W2079128105 hasIssue "3" @default.
- W2079128105 hasLocation W20791281051 @default.
- W2079128105 hasLocation W20791281052 @default.
- W2079128105 hasOpenAccess W2079128105 @default.
- W2079128105 hasPrimaryLocation W20791281051 @default.
- W2079128105 hasRelatedWork W1975256564 @default.
- W2079128105 hasRelatedWork W1981635576 @default.
- W2079128105 hasRelatedWork W1992414199 @default.
- W2079128105 hasRelatedWork W2042362036 @default.
- W2079128105 hasRelatedWork W2071782807 @default.
- W2079128105 hasRelatedWork W2081791238 @default.
- W2079128105 hasRelatedWork W2093587569 @default.
- W2079128105 hasRelatedWork W2314391848 @default.
- W2079128105 hasRelatedWork W4237322293 @default.
- W2079128105 hasRelatedWork W4238070260 @default.
- W2079128105 hasVolume "65" @default.
- W2079128105 isParatext "false" @default.
- W2079128105 isRetracted "false" @default.
- W2079128105 magId "2079128105" @default.
- W2079128105 workType "article" @default.